Bringing the 'entrepreneurial spirit' to American healthcare

Cara Livernois | | Health Exec | Policy & Regulations

Susannah Fox, the chief technology officer of the Department of Health and Human Services, recently shared her efforts and advice on encouraging innovation in the healthcare space.

As the entrepreneur-in-residence at the Robert Wood Johnson Foundation as well as serving as the associate director of the Internet Project at the Pew Research Center, Fox has been a leading innovative force for healthcare.gov.

In an interview for The Washington Post, Fox discussed those efforts to encourage innovation, including use of the IDEA Lab, an initiative for workers inside and outside of the department to explore unconventional solutions for problems in health and health care.

Click the link below for the full interview:

Trying to bring more innovation to American healthcare

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers
10 signs AI is ‘eating the world (of venture capital)’
Mangione now faces federal charges, death penalty in murder of UHC CEO
FDA issues Class I recall on counterfeit infusion pump batteries
FDA issues alert on PCNL sheath safety after patient death
DOJ sues CVS over unlawful opioid prescriptions and reimbursement

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.